166 related articles for article (PubMed ID: 36680436)
1. Emerging integrase strand transfer inhibitor drug resistance mutations among children and adults on ART in Tanzania: findings from a national representative HIV drug resistance survey.
Kamori D; Barabona G; Rugemalila J; Maokola W; Masoud SS; Mizinduko M; Sabasaba A; Ruhago G; Sambu V; Mushi J; Mgomella GS; Mcollogi JJ; Msafiri F; Mugusi S; Boniface J; Mutagonda R; Mlunde L; Amani D; Mboya E; Mahiti M; Rwebembera A; Ueno T; Pembe A; Njau P; Mutayoba B; Sunguya B
J Antimicrob Chemother; 2023 Mar; 78(3):779-787. PubMed ID: 36680436
[TBL] [Abstract][Full Text] [Related]
2. HIV virologic response, patterns of drug resistance mutations and correlates among adolescents and young adults: A cross-sectional study in Tanzania.
Rugemalila J; Kamori D; Kunambi P; Mizinduko M; Sabasaba A; Masoud S; Msafiri F; Mugusi S; Mutagonda R; Mlunde L; Amani D; Mboya E; Mahiti M; Ruhago G; Mushi J; Sambu V; Mgomella G; Jullu B; Maokola W; Njau P; Mutayoba B; Barabona G; Ueno T; Pembe A; Nagu T; Sunguya B; Aboud S
PLoS One; 2023; 18(2):e0281528. PubMed ID: 36821538
[TBL] [Abstract][Full Text] [Related]
3. High viral suppression and detection of dolutegravir-resistance associated mutations in treatment-experienced Tanzanian adults living with HIV-1 in Dar es Salaam.
Bwire GM; Aiko BG; Mosha IH; Kilapilo MS; Mangara A; Kazonda P; Swai JP; Swalehe O; Jordan MR; Vercauteren J; Sando D; Temba D; Shao A; Mauka W; Decouttere C; Vandaele N; Sangeda RZ; Killewo J; Vandamme AM
Sci Rep; 2023 Nov; 13(1):20493. PubMed ID: 37993493
[TBL] [Abstract][Full Text] [Related]
4. Trends in HIV-1 Drug Resistance Mutations from a U.S. Reference Laboratory from 2006 to 2017.
Kagan RM; Dunn KJ; Snell GP; Nettles RE; Kaufman HW
AIDS Res Hum Retroviruses; 2019 Aug; 35(8):698-709. PubMed ID: 31169022
[TBL] [Abstract][Full Text] [Related]
5. Pre-treatment and acquired HIV drug resistance in Dar es Salaam, Tanzania in the era of tenofovir and routine viral load monitoring.
Barabona G; Mahiti M; Masoud S; Mbelele P; Mgunya AS; Minja L; Sunguya B; Shigemi U; Matsuda M; Hachiya A; Iwatani Y; Lyamuya E; Ueno T
J Antimicrob Chemother; 2019 Oct; 74(10):3016-3020. PubMed ID: 31273377
[TBL] [Abstract][Full Text] [Related]
6. Acquired HIV drug resistance among adults living with HIV receiving first-line antiretroviral therapy in Rwanda: A cross-sectional nationally representative survey.
Musengimana G; Tuyishime E; Kiromera A; Malamba SS; Mulindabigwi A; Habimana MR; Baribwira C; Ribakare M; Habimana SD; DeVos J; Mwesigwa RCN; Kayirangwa E; Semuhore JM; Rwibasira GN; Suthar AB; Remera E
Antivir Ther; 2022 Jun; 27(3):13596535221102690. PubMed ID: 35593031
[TBL] [Abstract][Full Text] [Related]
7. High levels of pretreatment and acquired HIV drug resistance in Nicaragua: results from the first nationally representative survey, 2016.
Girón-Callejas A; García-Morales C; Mendizabal-Burastero R; Román M; Tapia-Trejo D; Pérez-García M; Quiroz-Morales VS; Juárez SI; Ravasi G; Vargas C; Gutiérrez R; Romero L; Solórzano A; Sajquim E; Northbrook S; Ávila-Ríos S; Reyes-Terán G
J Int AIDS Soc; 2019 Dec; 22(12):e25429. PubMed ID: 31860167
[TBL] [Abstract][Full Text] [Related]
8. Integrase Strand Transfer Inhibitor Resistance in Integrase Strand Transfer Inhibitor-Naive Persons.
Bailey AJ; Rhee SY; Shafer RW
AIDS Res Hum Retroviruses; 2021 Oct; 37(10):736-743. PubMed ID: 33683148
[TBL] [Abstract][Full Text] [Related]
9. Applying Next-Generation Sequencing to Track HIV-1 Drug Resistance Mutations Circulating in Portugal.
Pimentel V; Pingarilho M; Sebastião CS; Miranda M; Gonçalves F; Cabanas J; Costa I; Diogo I; Fernandes S; Costa O; Corte-Real R; Martins MRO; Seabra SG; Abecasis AB; Gomes P
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675962
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in Uganda.
Ndashimye E; Avino M; Olabode AS; Poon AFY; Gibson RM; Li Y; Meadows A; Tan C; Reyes PS; Kityo CM; Kyeyune F; Nankya I; Quiñones-Mateu ME; Arts EJ
J Antimicrob Chemother; 2020 Dec; 75(12):3525-3533. PubMed ID: 32853364
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and characteristics of HIV drug resistance among antiretroviral treatment (ART) experienced adolescents and young adults living with HIV in Ndola, Zambia.
Miti S; Handema R; Mulenga L; Mwansa JK; Abrams E; Frimpong C; Burke VM; Zulu M; Siwingwa M; Mwakazanga D; Kalibala S; Denison JA
PLoS One; 2020; 15(8):e0236156. PubMed ID: 32804970
[TBL] [Abstract][Full Text] [Related]
12. Limited emergence of resistance to integrase strand transfer inhibitors (INSTIs) in ART-experienced participants failing dolutegravir-based antiretroviral therapy: a cross-sectional analysis of a Northeast Nigerian cohort.
Abdullahi A; Kida IM; Maina UA; Ibrahim AH; Mshelia J; Wisso H; Adamu A; Onyemata JE; Edun M; Yusuph H; Aliyu SH; Charurat M; Abimiku A; Abeler-Dorner L; Fraser C; Bonsall D; ; Kemp SA; Gupta RK
J Antimicrob Chemother; 2023 Aug; 78(8):2000-2007. PubMed ID: 37367727
[TBL] [Abstract][Full Text] [Related]
13. Genotypic correlates of resistance to the HIV-1 strand transfer integrase inhibitor cabotegravir.
Rhee SY; Parkin N; Harrigan PR; Holmes S; Shafer RW
Antiviral Res; 2022 Dec; 208():105427. PubMed ID: 36191692
[TBL] [Abstract][Full Text] [Related]
14. High Level of HIV Drug Resistance and Virologic Nonsuppression Among Female Sex Workers in Ethiopia: A Nationwide Cross-Sectional Study.
Arimide DA; Amogne MD; Kebede Y; Balcha TT; Adugna F; Ramos A; DeVos J; Zeh C; Agardh A; Chih-Wei Chang J; Björkman P; Medstrand P
J Acquir Immune Defic Syndr; 2022 Apr; 89(5):566-574. PubMed ID: 34966147
[TBL] [Abstract][Full Text] [Related]
15. Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings.
Semengue ENJ; Armenia D; Inzaule S; Santoro MM; Dambaya B; Takou D; Teto G; Nka AD; Yagai B; Fabeni L; Chenwi C; Angong Beloumou G; Djupsa Ndjeyep SC; Colizzi V; Perno CF; Ceccherini-Silberstein F; Fokam J
J Antimicrob Chemother; 2021 Apr; 76(5):1277-1285. PubMed ID: 33501504
[TBL] [Abstract][Full Text] [Related]
16. Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy.
Svärd J; Mugusi S; Mloka D; Neogi U; Meini G; Mugusi F; Incardona F; Zazzi M; Sönnerborg A
PLoS One; 2017; 12(6):e0178942. PubMed ID: 28582463
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of integrase strand transfer inhibitor resistance mutations in antiretroviral-naive HIV-1-infected individuals in Cameroon.
Wenk BM; Mbunkah HA; Nsanwe NN; Mbu ET; Besong LM; Sama BA; Orock E; Leemann C; Metzner KJ
J Antimicrob Chemother; 2021 Jan; 76(1):124-129. PubMed ID: 32954411
[TBL] [Abstract][Full Text] [Related]
18. A Partially Multiplexed HIV Drug Resistance (HIVDR) Assay for Monitoring HIVDR Mutations of the Protease, Reverse-Transcriptase (PRRT), and Integrase (INT).
DeVos J; McCarthy K; Sewe V; Akinyi G; Junghae M; Opollo V; Nouhin J; Shafer R; Zeh C; Ramos A; Alexander H; Chang J
Microbiol Spectr; 2022 Jun; 10(3):e0177621. PubMed ID: 35510849
[TBL] [Abstract][Full Text] [Related]
19. Absence of Integrase Strand Transfer Inhibitor Associated Resistance in Antiretroviral Therapy Naïve and Experienced Individuals from Western India.
Karade S; Sen S; Sashindran VK
AIDS Res Hum Retroviruses; 2019 Jun; 35(6):567-571. PubMed ID: 30793915
[TBL] [Abstract][Full Text] [Related]
20. Primary resistance against integrase strand transfer inhibitors in integrase strand transfer inhibitor-naive patients failing first- and second-line ART in Tanzania.
Henerico S; Lyimo E; Makubi AN; Magesa D; Desderius B; Mueller A; Changalucha J; Kalluvya SE; Van Zyl G; Preiser W; Mshana SE; Kasang C
J Antimicrob Chemother; 2022 Oct; 77(11):3138-3143. PubMed ID: 36101479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
